Transforming growth factor β signal transduction

Journal of Leukocyte Biology

Volumn 71, Issue 5, 2002, Pages 731-740

  Dennler, Sylviane ^a   Goumans, Marie José ^a   Dijke, Peter Ten ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Immune system; Smad; Transcription factor

Indexed keywords

CYTOKINE; MEMBRANE PROTEIN; PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CYTOKINE RELEASE; GENE TARGETING; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL MEMBRANE; DNA-BINDING PROTEINS; HUMANS; IMMUNE SYSTEM; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0036587571     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (133)

1. Massagué, J. (1998) TGFβ signal transduction. Annu. Rev. Biochem. 67, 753-791.
2. Derynck, R., Feng, X. H. (1997) TGFβ receptor signaling. Biochim. Biophys. Acta 1333, F105-F150.
3. De Larco, J. E., Todaro, G. J. (1978) Growth factors from murine sarcoma virus transformed cells. Proc. Natl. Acad. Sci. USA 75, 4001-4005.
4. Shipley, G. D., Pittelkow, M. R., Wille Jr., J. J., Scott, R. E., Moses, H. L. (1986) Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium. Cancer Res. 46, 2068-2071.
5. Roberts, A. B. (1998) Molecular and cell biology of TGFβ. Miner. Electrolyte Metab. 24, 111-119.
6. Letterio, J. J., Roberts, A. B. (1998) Regulation of immune responses by TGFβ. Annu. Rev. Immunol. 16, 137-161.
7. Cerwenka, A., Swain, S. L. (1999) TGFβ1: immunosuppressant and viability factor for T lymphocytes. Microbes Infect. 1, 1291-1296.
8. Lebman, D. A., Edmiston, J. S. (1999) The role of TGFβ in growth, differentiation, and maturation of B lymphocytes. Microbes Infect. 1, 1297-1304.
9. Mason, A. J., Hayflick, J. S., Ling, N., Esch, F., Ueno, N., Ying, S. Y., Guillemin, R., Niall, H., Seeburg, P. H. (1985) Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-β. Nature 318, 659-663.
10. Murata, M., Eto, Y., Shibai, H., Sakai, M., Muramatsu, M. (1988) Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin βA chain. Proc. Natl. Acad. Sci. USA 85, 2434-2438.
11. Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., Wang, E. A. (1988) Novel regulators of bone formation: molecular clones and activities. Science 242, 1528-1534.
12. Goumans, M. J., Mummery. C. (2000) Functional analysis of the TGFβ receptor/Smad pathway through gene ablation in mice. Int. J. Dev. Biol. 44, 253-265.
13. Blobe, G. C., Schiemann, W. P., Lodish, H. F. (2000) Role of transforming growth factor β in human disease. N. Engl. J. Med. 342, 1350-1358.
14. Pircher, R., Jullien, P., Lawrence, D. A. (1986) Beta-transforming growth factor is stored in human blood platelets as a latent high molecular weight complex. Biochem. Biophys. Res. Commun. 136, 30-37.
15. Lawrence, D. A. (2001) Latent-TGFβ: an overview. Mol. Cell. Biochem. 219, 163-170.
16. Phillips, D. J. (2000) Regulation of activin's access to the cell: why is mother nature such a control freak? Bioessays 22, 689-696.
17. Miyazono, K. (2000) Positive and negative regulation of TGFβ signaling. J. Cell Sci. 113, 1101-1109.
18. Wakefield, L. M., Winokur, T. S., Hollands, R. S., Christopherson, K., Levinson, A. D., Sporn, M. B. (1990) Recombinant latent transforming growth factor β1 has a longer plasma half-life in rats than active transforming growth factor β1, and a different tissue distribution. J. Clin. Investig. 86, 1976-1984.
19. O'Connor-McCourt, M. D., Wakefield, L. M. (1987) Latent transforming growth factor-β in serum. A specific complex with α2-macroglobulin. J. Biol. Chem. 262, 14090-14099.
20. Vaughan, J. M., Vale, W. W. (1993) α2-Macroglobulin is a binding protein of inhibin and activin. Endocrinology 132, 2038-2050.
21. Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., Karlsson, S. (1993) Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770-774.
22. Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
23. Letterio, J. J., Geiser, A. G., Kulkarni, A. B., Roche, N. S., Sporn, M. B., Roberts, A. B. (1.994) Maternal rescue of transforming growth factor β1 null mice. Science 264, 1936-1938.
24. Itoh, S., Itoh, F., Goumans, M-J., ten Dijke, P. (2000) Signaling of transforming growth factor β family members through Smad proteins. Eur. J. Biochem. 267, 6954-6967.
25. Massagué, J., Wotton, D. (2000) Transcriptional control by the TGFβ/ Smad signaling system. EMBO J. 19, 1745-1754.
26. Attisano, L., Wrana, J. L. (2000) Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12, 235-243.
27. Christ, M., McCartney-Francis, N. L., Kulkarni, A. B., Ward, J. M., Mizel, D. E., Mackall, C. L., Gress, R. E., Hines, K. L., Tian, H., Karlsson, S., et al. (1994) Immune dysregulation in TGFβ1-deficient mice. J. Immunol. 153, 1936-1946.
28. Yaswen, L., Kulkarni, A. B., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., Longenecker, G., Mozes, E., Karlsson, S. (1996) Autoimmune manifestations in the transforming growth factor β1 knockout mouse. Blood 87, 1439-1445.
29. Geiser, A. G., Letterio, J. J., Kulkarni, A. B., Karlsson, S., Roberts, A. B., Sporn, M. B. (1993) Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc. Natl. Acad. Sci. USA 90, 9944-9948.
30. Hines, K. L., Kulkarni, A. B., McCarthy, J. B., Tian, H., Ward, J. M., Christ, M., McCartney-Francis, N. L., Furcht, L. T., Karlsson, S., Wahl, S. M. (1994) Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice. Proc. Natl. Acad. Sci. USA 91, 5187-5191.
31. Sillett, H. K., Cruickshank, S. M., Southgate, J., Trejdosiewicz, L. K. (2001) Transforming growth factor β promotes 'death by neglect' in post-activated human T cells. Immunology 102, 310-316.
32. Chen, W., Frank, M. E., Jim W., Wahl, S. M. (2001) TGF-β released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 14, 715-725.
33. Hjertner, O., Hjorth-Hansen, H., Borset, M., Seidel, C., Waage, A., Sundan, A. (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 97, 516-522.
34. Kawamura, C., Kizaki, M., Yamato, K., Uchida, H., Fukuchi, Y., Hattori, Y., Koseki, T., Nishihara, T., Ikeda, Y. (2000) Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3. Blood 96, 2005-2011.
35. Kimura, N., Matsuo, R., Shibuya, H., Nakashima, K., Taga, T. (2000) BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J. Biol. Chem. 275, 17647-17652.
36. Ludviksson, B. R., Seegers, D., Resnick, A. S., Strober, W. (2000) The effect of TGF-β1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur. J. Immunol. 30, 2101-2111.
37. van Ginkel, F. W., Wahl, S. M., Kearney, J. F., Kweon, M. N., Fujihashi, K., Burrows, P., D., Kiyono, H., McGhee, J. R. (1999) Partial IgA-deficiency with increased Th2-type cytokines in TGF-β1 knockout mice. J. Immunol. 163, 1951-1957.
38. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., Massagué, J. (1994) Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
39. Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C-H., Miyazono, K. (1993) Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor. Cell 75, 681-692.
40. Lin, H. Y., Wang, X-F., Ng-Eaton, E., Weinberg, R. A., Lodish, H. F. (1992) Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785.
41. Oh, S. P., Seki, T., Goss, K. A., Imamura, T., Yi, Y, Donahoe, P. K., Li, L., Miyazono, K., ten Dijke, P., Kim, S., Li, E. (2000) Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA 97, 2626-2631.
42. Mathews, L. S., Vale, W. W. (1991) Expression cloning of an activin receptor, a predicted transmembrane serine kinase. Cell 65, 973-982.
43. Attisano, L., Careamo, J., Ventura, F., Weis, F. M., Massagué, J., Wrana, J. L. (1993) Identification of human activin and TGFβ type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75, 671-680.
44. ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K., Heldin, C-H. (1994) Characterization of type I receptors for transforming growth factor-β and activin. Science 264, 101-104.
45. Rosenzweig, B. L., Imamura, T., Okadome, T., Cox, G. N., Yamashita, H., ten Dijke, P., Heldin, C-H., Miyazono, K. (1995) Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA 92, 7632-7636.
46. Liu, F., Ventura, F., Doody, J., Massagué, J. (1995) Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. Mol. Cell. Biol. 15, 3479-3486.
47. Lopez-Casillas, F., Wrana, J. L., Massagué, J. (1993) Betaglycan presents ligand to the TGFβ signaling receptor. Cell 73, 1435-1444.
48. Cheifetz, S., Bellon, T., Cales, C., Vera, S., Bernabeu, C., Massagué, J., Letarte, M. (1992) Endoglin is a component of the transforming growth factor-β receptor in human endothelial cells. J. Biol. Chem. 267, 19027-19030.
49. Fortunel, N. O., Hatzfeld, A., Hatzfeld, J. A. (2000) Transforming growth factor β: pleiotropic role in the regulation of hematopoiesis. Blood 96, 2022-2036.
50. Kehrl, J. H., Roberts, A. B., Wakefield, L. M., Jakowlew, S., Sporn, M. B., Fauci, A. S. (1986) Transforming growth factor β is an important immunomodulatory protein for human B lymphocytes. J. Immunol. 137, 3855-3860.
51. Buske, C., Becker, D., Feuring-Buske, M., Hannig, H., Griesinger, F., Hiddemann, W., Wormann, B. (1998) TGFβ and its receptor complex in leukemic B-cell precursors. Exp. Hematol. 26, 1155-1161.
52. Cazac, B. B., Roes, J. (2000) TGFβ receptor controls B cell responsiveness and induction of IgA in vivo. Immunity 13, 443-451.
53. Gorelik, L., Flavell, R. A. (2000) Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12, 171-181.
54. Abdollah, S., Macías-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L., Wrana, J. L. (1997) TβRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272, 27678-27685.
55. Souchelnytskyi, S., Tamaki, K., Engstrom, U., Wernstedt, C., ten Dijke, P., Heldin, C-H. (1997) Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-β signaling. J. Biol. Chem. 272, 28107-28115.
56. Macías-Silva, M., Abdollah, S., Hoodless, P. A., Pirone, R., Attisano, L., Wrana, J. L. (1996) MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224.
57. Hoodless, P. A., Haerry, T., Abdollah, S., Stapleton, M., O'Connor, M. B., Attisano, L., Wrana, J. L. (1996) MADB1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489-500.
58. Nakao, A., Imamura, T., Souchelnytskyi, S., Kawabata, M., Ishisaki, A., Oeda, E., Tamaki, K., Hanai, J., Heldin, C-H., Miyazono, K., ten Dijke, P. (1997) TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16, 5353-5362.
59. Wu, J. W., Fairman, R., Penry, J., Shi, Y. (2001) Formation of a stable heterodimer between Smad2 and Smad4. J. Biol. Chem. 276, 20688-20694.
60. Correia, J. J., Chacko, B. M., Lam, S. S., Lin, K. (2001) Sedimentation studies reveal a direct role of phosphorylation in Smad3: Smad4 homo-and hetero-trimerization. Biochemistry 40, 1473-1482.
61. Kawabata, M., Inoue, H., Hanyu, A., Imamura, T., Miyazono, K. (1998) Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17, 4056-4065.
62. Nakao, A., Afrakhte, M., Morøn, A., Nakayama, T., Christian, J., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N-E., Heldin, C-H., ten Dijke, P. (1997) Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling. Nature 389, 631-635.
63. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., Miyazono, K. (1997) Smad6 inhibits signalling by the TGF-β superfamily. Nature 389, 622-626.
64. Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y. Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone Jr., M. A., Wrana, J. L., Falb, D. (1997) The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165-1173.
65. Hata, A., Lagna, G., Massagué, J., Hemmati-Brivanlou, A. (1998) Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186-197.
66. Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., Wrana, J. L. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation. Mol. Cell 6, 1365-1375.
67. Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., Miyazono, K. (2001) Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276, 12477-12480.
68. Hata, A., Lo, R. S., Wotton, D., Lagna, G., Massagué, J. (1997) Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388, 82-87.
69. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., Kinzler, K. W., Vogelstein, B., Kern, S. E. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1, 611-617.
70. Dennler, S., Itoh, S., Vivien, D., ten Dijke, P., Huet, S., Gauthier, J. M. (1998) Direct binding of Smad3 and Smad4 to critical TGFβ-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100.
71. Shi, Y., Wang, Y. F., Jayaraman, L., Yang, H., Massagué, J., Pavletich, N. P. (1998) Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell 94, 585-594.
72. Dennler, S., Huet, S., Gauthier, J. M. (1999) A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 18, 1643-1648.
73. Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M., Miyazono, K. (1999) Alternatively spliced variant of Smad2 lacking exon 3. Comparison with wild-type Smad2 and Smad3. J. Biol. Chem. 274, 703-709.
74. Shi, Y. (2001) Structural insights on Smad function in TGFβ signaling. Bioessays 23, 223-232.
75. Qing, J., Zhang, Y., Derynck, R. (2000) Structural and functional characterization of the transforming growth factor-β-induced Smad3/c-Jun transcriptional cooperativity. J. Biol. Chem. 275, 38802-38812.
76. Chen, X., Rubock, M. J., Whitman, M. (1996) A transcriptional partner for MAD proteins in TGF-β signalling. Nature 383, 691-696.
77. Germain, S., Howell, M., Esslemont, G. M., Hill, C. S. (2000) Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev. 14, 435-451.
78. Liu, F., Hata, A., Baker, J. C., Doody, J., Carcamo, J., Harland, R. M., Massagué, J. (1996) A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 38, 620-623.
79. Feng, X. H., Zhang, Y., Wu, R. Y., Derynck, R. (1998) The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGFβ-induced transcriptional activation. Genes Dev. 12, 2153-2163.
80. Janknecht, R., Wells, N. J., Hunter, T. (1998) TGFβ-stimulated cooperation of Smad proteins with the coactivators CBP/p300. Genes Dev. 12, 2114-2119.
81. Nishihara, A., Hanai, J. I., Okamoto, N., Yanagisawa, J., Kato, S., Miyazono, K., Kawabata, M. (1998) Role of p300, a transcriptional coactivator, in signalling of TGFβ. Genes Cells 3, 613-623.
82. Shen, X., Hu, P. P., Liberati, N, T., Datto, M. B., Frederick, J, P., Wang, X-F. (1998) TGFβ-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol. Biol. Cell 9, 3309-3319.
83. Itoh, S., Ericsson, J., Nishikawa, J., Heldin, C-H., ten Dijke, P. (2000) The transcriptional co-activator P/CAF potentiates TGFβ/Smad signaling. Nucleic Acids Res. 28, 4291-4298.
84. Luo, K., Stroschein, S. L., Wang, W., Chen, D., Martens, E., Zhou, S., Zhou, Q. (1999) The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling. Genes Dev. 13, 2196-2206.
85. Wotton, D., Lo, R. S., Lee, S., Massagué, J. (1999) A Smad transcriptional corepressor. Cell 97, 29-39.
86. Liu, X., Sun, Y., Weinberg, R, A., Lodish, H. F. (2001) Ski/Sno and TGF-β signaling. Cytokine Growth Factor Rev. 12, 1-8.
87. Bonni, S., Wang, H. R., Causing, C. G., Kavsak, P., Stroschein, S. L., Luo, K., Wrana, J. L. (2001) TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat. Cell Biol. 3, 587-595.
88. Stroschein, S. L., Wang, W., Zhou, S., Zhou, Q., Luo, K. (1999) Negative feedback regulation of TGF-β signaling by the SnoN oncoprotein. Science 286, 771-774.
89. Afrakhte, M., Morén, A., Jossan, S., Itoh, S., Sampath, K., Westermark, B., Heldin, C-H., Heldin, N-E., ten Dijke, P. (1998) Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members. Biochem. Biophys. Res. Commun. 249, 505-511.
90. Bitzer, M., von Gersdofff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M., Bottinger, E. P. (2000) A mechanism of suppression of TGF-β/SMAD signaling by NF-κB/ReA. Genes Dev. 14, 187-197.
91. Ulloa, L., Doody, J., Massagué, J. (1999) Inhibition of transforming growth factor β/SMAD signalling by the interferon γ/STAT pathway. Nature 397, 710-713.
92. Yang, X., Letterio, J. J., Lechleider, R. J., Chen, L., Hayman, R., Gu, H., Roberts, A. B., Deng, C. (1999) Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGFβ. EMBO J. 18, 1280-1291.
93. Ashcroft, G. S., Yang, X., Glick, A. B., Weinstein, M., Letterio, J. L., Mizel, D. E., Anzano, M., Greenwell-Wild, T., Wahl, S. M., Deng, C., Roberts, A. B. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat. Cell Biol. 1, 260-266.
94. Nakao, A., Miike, S., Hatano, M., Okumura, K., Tokuhisa, T., Ra, C., Iwamoto, I. (2000) Blockade of transforming growth factor β/Smad signaling in T cells by everexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J. Exp. Med. 192, 151-158.
95. Xie, X. Q., Pardali, E., Holm, M., Sideras, P., Grundstrom, T. (1999) AML and Ets proteins regulate the Iα1 germ-line promoter. Eur. J. Immunol. 29, 488-498.
96. Pardali, E., Xie, X. Q., Tsapogas, P., Itoh, S., Arvanitidis, K., Heldin, C-H., ten Dijke, P., Grundstrom, T., Sideras, P. (2000) Smad and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes. J. Biol. Chem. 275, 3552-3560.
97. Hanai, J., Chen, L. F., Kanno, T., Ohtani-Fujita, N., Kim, W. Y., Guo, W. H., Imamura, T., Ishidou, Y., Fukuchi, M., Shi, M. J., Stavnezer, J., Kawabata, M., Miyazono, K., Ito, Y. (1999) Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274, 31577-31582.
98. Zhang, Y., Derynck, R. (2000) Transcriptional regulation of the transforming growth factor-β-inducible mouse germline Igα constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol Chem. 275, 16979-16985.
99. Shi, M. J., Park, S. R., Kim, P. H., Stavnezer, J. (2001) Roles of Ets proteins, NFκB and nocodazole in regulating induction of transcription of mouse germline Igα RNA by transforming growth factor β1. Int. Immunol. 13, 733-746.
100. Gorelik, L., Fields, P. E., Flavell, R. A. (2000) Cutting edge: TGFβ inhibits Th type 2 development through inhibition of GATA-3 expression. J. Immunol. 165, 4773-4777.
101. Heath, V. L., Murphy, E. E., Crain, C., Tomlinson, M. G., O'Garra, A. (2000) TGFβ1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur. J. Immunol. 30, 2639-2649.
102. Ishisaki, A., Yamato, K., Hashimoto, S., Nakao, A., Tamaki, K., Nonaka, K., ten Dijke, P., Sugino, H., Nishihara, T. (1999) Differential inhibition of Smad6 and Smad7 on bone morphogenetic protein- and activin-mediated growth arrest and apoptosis in B cells. J. Biol. Chem. 274, 13637-13642.
103. Yamato, K., Hashimoto, S., Imamura, T., Uchida, H., Okahashi, N., Koseki, T., Ishisaki, A., Kizaki, M., Miyazono, K., Ikeda, Y., Nishihara, T. (2001) Activation of the p21(CIP1/WAF1) promoter by bone morphogenetic protein-2 in mouse B lineage cells. Oncogene 20, 4383-4392.
104. Kee, B. L., Rivera, R. R., Murre, C, (2001) Id3 inhibits B lymphocyte progenitor growth and survival in response to TGFβ. Nat. Immun. 2, 242-247.
105. Bright, J., Kerr, L., Sriram, S. (1997) TGFβ inhibits IL-2-induced tyrosine phosphorylation and activation of JAK-1 and STAT5 in T lymphocytes. J. Immunol. 159, 175-183.
106. Pardoux, C., Ma, X., Gobert, S., Pellegrini, S., Mayeux, P., Gay, F., Trinchieri, G., Chouaib, S. (1999) Downregulation of interleukin-12 (IL-12) responsiveness in human T cells by transforming growth factor-β: relationship with IL-12 signaling. Blood 93, 1448-1455.
107. Sudarshan, C., Galon, J., Zhou, Y-J., O'Shea, J. J. (1999) TGFβ does not inhibit IL-12 and IL-2-induced activation of Janus kinases and STATs. J. Immunol. 162, 2974-2981.
108. Tzachanis, D., Freeman, G. J., Hirano, N., van Puijenbroek, A. A., Delfs, M. W., Berezovskaya, A., Nadler, L. M., Boussiotis, V. A. (2001) Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat. Immunol. 2, 1174-1182.
109. Arsura, M., Wu, M., Sonenshein, G. E. (1996) TGFβ1 inhibits NFκB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκBα. Immunity 5, 31-40.
110. Yanagisawa, K., Osada, H., Masuda, A., Kondo, M., Saito, T., Yatabe, Y., Takagi, K., Takahashi, T., Takabashi, T. (1998) Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-β in human normal lung epithelial cells. Oncogene 17, 1743-1747.
111. Dai, J. L., Bansal, R. K., Kern, S. E. (1.999) G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: phenotypes reversed by a tumorigenic mutation. Proc. Natl. Acad. Sci. USA 96, 1427-1432.
112. Francis, J. M., Heyworth, C. M., Spooncer, E., Pierce, A., Dexter, T. M., Whetton, A. D. (2000) Transforming growth factor-β1 induces apoptosis independently of p53 and selectively reduces expression of Bcl-2 in multipotent hematopoietic cells. J. Biol. Chem. 275, 39137-39145.
113. Motyl, T., Grzelkowska, K., Zimowska, W., Skierski, J., Wareski, P., Ploszaj, T., Trzeciak, L. (1998) Expression of bcl-2 and bax in TGF-β1-induced apoptosis of L1210 leukemic cells. Eur. J. Cell Biol. 75, 367-374.
114. Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., Matsumoto, K. (1995) Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011.
115. Perlman, R., Schiemann, W. P., Brooks, M. W., Lodish, H. F., Weinberg, R. A. (2001) TGFβ-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat. Cell. Biol. 3, 708-714.
116. Gold, L. I. (1991) The role for transforming growth factor-β (TGF-β) in human cancer. Crit. Rev. Oncog. 10, 303-360.
117. de Caestecker, M. P., Pick, E., Roberts, A. B. (2000) Role of transforming growth factor β signaling in cancer. J. Natl. Cancer Inst. 92, 1388-1402.
118. Markowitz, S. D., Roberts, A. B. (1996) Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev. 7, 93-102.
119. DeCoteau, J. F., Knaus, P. I., Yankelev, H., Reis, M. D., Lowsky, R., Lodish, H. F., Kadin, M. E. (1997) Loss of functional cell surface transforming growth factor β (TGFβ) type 1 receptor correlates with insensitivity to TGFβ in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 94, 5877-5881.
120. Knaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., Yankelev, H., Hille, M., Kadin, M. E., Lodish, H. F. (1996) A dominant inhibitory mutant of the type II transforming growth factor β receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol. Cell. Biol. 16, 3480-3489.
121. Schiemann, W. P., Pfeiferm, W. M., Levi, E., Kadin, M. E., Lodish, H. F. (1999) A deletion in the gene for transforming growth factor β type I receptor abolishes growth regulation by transforming growth factor β in a cutaneous T-cell lymphoma. Blood 94, 2854-2861.
122. Kadin, M. E., Cavaille-Coll. M. W., Gertz, R., Massagué, J., Cheifetz, S., George, D. (1994) Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. Natl. Acad. Sci. USA 91, 6002-6006.
123. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., Kern, S. E. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353.
124. Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Maki, K., Ogawa, S., Chiba, S., Mitani, K., Hirai, H. (2001) Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis. Oncogene 20, 88-96.
125. Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K., Markowitz, S. D., Kinzler, K. W., Vogelstein, B. (1996) Mad-related genes in the human. Nat. Genet. 13, 347-349.
126. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L. C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., Attisano, L. (1996) MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552.
127. Kurokawa, M., Mitani, K., Irie, K., Matsuyama, T., Takahashi, T., Chiba, S., Yazaki, Y., Matsumoto, K., Hirai, H. (1998) The oncoprotein Evi-1 represses TGFβ signalling by inhibiting Smad3. Nature 394, 92-96.
128. Izutsu, K., Kurokawa, M., Imai, Y., Maki, K., Mitani, K., Hirai, H. (2001) The corepressor CtBP interacts with Evi-1 to repress transforming growth factor β signaling. Blood 97, 2815-2822.
129. Chaganti, R. S., Balazs, I., Jhanwar, S. C., Murty, V. V., Koduru, P. R., Grzeschik, K. H., Stavnezer, E. (1986) The cellular homologue of the transforming gene of SKV avian retrovirus maps to human chromosome region 1q22-q24. Cytogenet. Cell Genet. 43, 181-186.
130. Kees, U. R., Lukeis, R., Ford, J., Willoughby, M. L., Garson, O. M. (1990) Establishment and characterization of a childhood pre-B acute lymphoblastic leukemia cell line. PER-278, with chromosome translocations t(1;19) and t(1;9). Cancer Genet. Cytogenet. 46, 201-208.
131. Gorelik, L., Flavell, R. A. (2001) Immune-mediated eradication of tumors through the blockage of transforming growth factor-β signaling in T cells. Nat. Med. 7, 1118-1122.
132. Jachimczak, P., Bogdahn, U., Schneider, J., Behl, C., Meixensberger, J., Apfel, R., Dorries, R., Schlingensiepen, K. H., Brysch, W. (1993) The effect of transforming growth factor-β2-specific phosphorothioate-antisense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma. J. Neurosurg. 78, 944-951.
133. Fakhrai, H., Dorigo, O., Shawler, D. L., Lin, H., Mercola, D., Black, K. L., Royston, I., Sobol, R. E. (1996) Eradication of established intracranial rat gliomas by transforming growth factor β antisense gene therapy. Proc. Natl. Acad. Sci. USA 93, 2909-2914.